Tesamorelin and ipamorelin are often discussed as a stack, but no FDA-approved blend exists. Learn how they differ, common research protocols, and safety.
Tesamorelin and ipamorelin are two different growth hormone–related peptides that are often discussed as a stack, but no FDA-approved product combines them. Tesamorelin is approved in the United States only for HIV-associated lipodystrophy, and ipamorelin is not FDA-approved for human use at all. Anyone considering either peptide should speak with a licensed healthcare professional first.
Most searches for tesamorelin ipamorelin come down to three questions: what each peptide does, whether a tesamorelin ipamorelin blend makes sense, and what the risks are. The short answer is that the two compounds work through different receptors, so stacking them is a research idea rather than an approved treatment.
What Tesamorelin and Ipamorelin Are
Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH). It binds GHRH receptors in the pituitary and triggers growth hormone (GH) release, which in turn raises IGF-1.
Ipamorelin is a synthetic pentapeptide that acts on a different target: the ghrelin receptor, also called the growth hormone secretagogue receptor. Early research described it as relatively selective for GH, with less effect on cortisol or prolactin than older secretagogues.
- Tesamorelin: GHRH analog, sold as Egrifta for HIV-associated lipodystrophy.
- Ipamorelin: ghrelin receptor agonist, sold for research use only.
- Both: given by subcutaneous injection in clinical and research settings.
Tesamorelin vs Ipamorelin: Key Differences
The two peptides are not interchangeable. They act on separate receptors, have different half-lives, and have very different regulatory status.
| Feature | Tesamorelin | Ipamorelin |
|---|---|---|
| Class | GHRH analog | Ghrelin receptor agonist |
| Receptor | GHRH receptor | GHS-R1a |
| FDA status | Approved for HIV-associated lipodystrophy | Not approved for human use |
| Typical clinical dose | 2 mg daily for the approved indication | No approved dose; research amounts vary |
| Half-life | About 30–40 minutes | About 2 hours |
| Best-studied effect | Visceral fat reduction and GH/IGF-1 increase | GH pulse stimulation |
Because the receptors differ, some researchers describe the pair as complementary rather than redundant. That idea is the basis of most tesamorelin ipamorelin stack discussions.
Can You Take Tesamorelin and Ipamorelin Together?
No FDA-approved tesamorelin and ipamorelin combination exists, and no large clinical trial has tested the pair as a blend. Any combined use is therefore experimental and, in the US, outside approved medical practice.
In theory, pairing a GHRH analog with a ghrelin receptor agonist could produce a larger GH pulse than either alone, because the two pathways amplify each other. Small studies of other GHRH-plus-secretagogue pairs support that concept, but they do not prove that a tesamorelin/ipamorelin blend is safe or effective.
Combining tesamorelin and ipamorelin is a research concept, not an approved therapy.
Why People Stack Tesamorelin with Ipamorelin
Most interest in a tesamorelin ipamorelin protocol comes from three claims: larger GH pulses, better fat loss, and preserved muscle. Only the first has a clear mechanism.
- Additive GH release: GHRH and ghrelin pathways act on different pituitary receptors, so combining them can amplify GH output.
- Visceral fat: Tesamorelin has trial data for visceral fat reduction in one patient group; ipamorelin does not.
- Body composition: No controlled trial has tested the blend for muscle gain or fat loss in healthy adults.
People also compare it with other secretagogues. If you are weighing alternatives, cjc-1295 ipamorelin vs tesamorelin is a common comparison because CJC-1295 and tesamorelin are both GHRH analogs, while ipamorelin stays the same.
Blends, Ratios, and Reconstitution in Research
Since no pharmaceutical combination exists, most tesamorelin ipamorelin products sold online are compounded or research-grade powders. Vendors invent ratios and vial sizes that do not match any approved product.
A frequently listed example is a 2x blend tesamorelin 10mg ipamorelin 5mg, which implies twice as much tesamorelin as ipamorelin by mass. Another common label is tesamorelin/ipamorelin 12 2mg reconstitution, meaning a 12 mg total vial mixed with a set volume of bacteriostatic water.
Those numbers are vendor conventions, not clinical dosing. Peptide powders require correct reconstitution, refrigeration, and sterile technique, and a concentration error can lead to an unintended dose.
Safety, Side Effects, and Legal Status
Tesamorelin is FDA-approved only for HIV-associated lipodystrophy, not for general weight loss or anti-aging. Labeled side effects include injection-site reactions, joint pain, swelling, and changes in blood sugar. It also raises IGF-1, which is why it is not recommended for people with active cancer.
Ipamorelin is not FDA-approved for human use in the United States. Human safety data are limited, and the long-term consequences of repeatedly raising GH and IGF-1 are not well understood.
Both peptides are prescription-only in the US where they are legal at all. Gray-market sourcing adds risk: the same sites that list tesamorelin often advertise where to buy bpc-157 and tb-500, with no guarantee of purity, sterility, or actual peptide content. Consult a healthcare professional before considering any peptide protocol.
What Users Report Online
Forums and social media are full of anecdotal tesamorelin reddit before and after posts describing changes in waist size or energy. These reports are uncontrolled, often involve several peptides at once, and rarely include bloodwork or medical supervision.
Individual anecdotes cannot establish whether a tesamorelin ipamorelin blend works or is safe. Treat them as stories, not evidence.
The Bottom Line
Tesamorelin and ipamorelin are distinct peptides with distinct receptors, and no regulator has approved them as a combination. Tesamorelin has one narrow approved use; ipamorelin has none. Anyone curious about a tesamorelin ipamorelin injection protocol should treat it as experimental and talk to a qualified healthcare provider first.
Frequently Asked Questions
Can you take tesamorelin and ipamorelin together?
In research and community settings, people often discuss stacking them, but no FDA-approved combination product exists and no large clinical trial has tested the pair. Using them together would be experimental, and the two peptides act on different receptors, so results cannot be assumed from either one alone. Talk with a licensed healthcare professional before considering any combination.
What is the difference between tesamorelin and ipamorelin?
Tesamorelin is a GHRH analog that is FDA-approved only for HIV-associated lipodystrophy, while ipamorelin is a ghrelin receptor agonist that is not FDA-approved for human use. They bind different receptors, have different half-lives, and have very different amounts of human safety data. That is why they are usually described as complementary rather than interchangeable.
Is tesamorelin better than ipamorelin for fat loss?
Tesamorelin has clinical trial data for visceral fat reduction in adults with HIV-associated lipodystrophy, which is its only approved use. Ipamorelin has no approved human use and limited controlled data on fat loss. Comparing the two directly for general weight loss is not supported by strong evidence.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.